معرفی
Xingguang Luo is an Assistant Professor and Associate Research Scientist in the Department of Psychiatry at Yale School of Medicine. His academic career spans over two decades with significant contributions to psychiatric genetics and neuroscience research.
His educational background includes an MD from Shanghai Medical University (2000), followed by postdoctoral training at Yale University (2000-2003). He served as an Assistant Professor at Yale University School of Medicine from 2006-2012 before advancing to his current position.
Dr. Luo's research focuses on the intersection of psychiatry, genetics, and neuroscience, with particular emphasis on substance use disorders, schizophrenia, depression, and sleep disorders. His work employs advanced genomic techniques including genome-wide association studies, methylome-wide analyses, and polygenic risk scoring to understand the biological underpinnings of mental illness. He has made significant contributions to understanding the genetic architecture of alcoholism through NIH-funded projects including R01 grants on alcoholism genetics and R21 grants on substance co-dependence.
His recent publications demonstrate a strong trajectory in psychiatric genetics research, with increasing focus on integrating multi-omics approaches with neuroimaging and clinical phenotypes. His work frequently appears in high-impact journals covering schizophrenia, addiction, and mood disorders, with particular emphasis on gene-environment interactions and biomarker discovery.
Dr. Luo maintains active collaborations with leading researchers at Yale including Chiang-Shan Ray Li, Joel Gelernter, and John Krystal. His research team frequently publishes on topics ranging from genetic risk variants to neurobiological mechanisms underlying psychiatric conditions.
He has received consistent NIH funding for his research on alcoholism genetics, including projects focused on fine-mapping risk loci in ADH gene cluster and ALDH2 gene, deep sequencing of glutamatergic pathway genes in alcohol and nicotine co-dependence, and post-GWAS transcriptome-wide LncRNA profiling in alcoholism.